210 related articles for article (PubMed ID: 24496672)
1. Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response.
Han XQ; Gong ZJ; Xu SQ; Li X; Wang LK; Wu SM; Wu JH; Yang HF
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):10-17. PubMed ID: 24496672
[TBL] [Abstract][Full Text] [Related]
2. Advanced Glycated End Products Alter Neutrophil Effect on Regulation of CD
Lu H; Xu S; Liang X; Dai Y; Huang Z; Ren Y; Lin J; Liu X
Inflammation; 2019 Apr; 42(2):559-571. PubMed ID: 30343390
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products.
Chen YJ; Sheu ML; Tsai KS; Yang RS; Liu SH
PLoS One; 2013; 8(6):e66611. PubMed ID: 23776688
[TBL] [Abstract][Full Text] [Related]
4. Advanced Glycation End Products of Bovine Serum Albumin Suppressed Th1/Th2 Cytokine but Enhanced Monocyte IL-6 Gene Expression via MAPK-ERK and MyD88 Transduced NF-κB p50 Signaling Pathways.
Shen CY; Wu CH; Lu CH; Kuo YM; Li KJ; Hsieh SC; Yu CL
Molecules; 2019 Jul; 24(13):. PubMed ID: 31277476
[TBL] [Abstract][Full Text] [Related]
5. Effect of iodine excess on Th1, Th2, Th17, and Treg cell subpopulations in the thyroid of NOD.H-2h4 mice.
Yang X; Gao T; Shi R; Zhou X; Qu J; Xu J; Shan Z; Teng W
Biol Trace Elem Res; 2014 Jun; 159(1-3):288-96. PubMed ID: 24740393
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end products downregulates peroxisome proliferator-activated receptor γ expression in cultured rabbit chondrocyte through MAPK pathway.
Yang Q; Chen C; Wu S; Zhang Y; Mao X; Wang W
Eur J Pharmacol; 2010 Dec; 649(1-3):108-14. PubMed ID: 20863825
[TBL] [Abstract][Full Text] [Related]
7. IL-25 downregulates Th1/Th17 immune response in an IL-10-dependent manner in inflammatory bowel disease.
Su J; Chen T; Ji XY; Liu C; Yadav PK; Wu R; Yang P; Liu Z
Inflamm Bowel Dis; 2013; 19(4):720-8. PubMed ID: 23429464
[TBL] [Abstract][Full Text] [Related]
8. SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth.
Berger H; Végran F; Chikh M; Gilardi F; Ladoire S; Bugaut H; Mignot G; Chalmin F; Bruchard M; Derangère V; Chevriaux A; Rébé C; Ryffel B; Pot C; Hichami A; Desvergne B; Ghiringhelli F; Apetoh L
Cancer Res; 2013 Jun; 73(12):3578-90. PubMed ID: 23619236
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits gene expression of receptor for advanced glycation end-products (RAGE) in hepatic stellate cells in vitro by elevating PPARγ activity and attenuating oxidative stress.
Lin J; Tang Y; Kang Q; Feng Y; Chen A
Br J Pharmacol; 2012 Aug; 166(8):2212-27. PubMed ID: 22352842
[TBL] [Abstract][Full Text] [Related]
10. Recovery Profiles of T-Cell Subsets Following Low-Dose Total Body Irradiation and Improvement With Cinnamon.
Zheng X; Guo Y; Wang L; Zhang H; Wang S; Wang L; An L; Zhou X; Li X; Yao C
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1118-26. PubMed ID: 26475064
[TBL] [Abstract][Full Text] [Related]
11. Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Inoue H
Protein Pept Lett; 2008; 15(8):850-3. PubMed ID: 18855759
[TBL] [Abstract][Full Text] [Related]
12. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease.
Tian Y; Wang C; Ye Z; Xiao X; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6434-41. PubMed ID: 22918640
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end-products induce heparanase expression in endothelial cells by the receptor for advanced glycation end products and through activation of the FOXO4 transcription factor.
An XF; Zhou L; Jiang PJ; Yan M; Huang YJ; Zhang SN; Niu YF; Ten SC; Yu JY
Mol Cell Biochem; 2011 Aug; 354(1-2):47-55. PubMed ID: 21461610
[TBL] [Abstract][Full Text] [Related]
14. Green tea epigallocatechin-3-gallate modulates differentiation of naïve CD4⁺ T cells into specific lineage effector cells.
Wang J; Pae M; Meydani SN; Wu D
J Mol Med (Berl); 2013 Apr; 91(4):485-95. PubMed ID: 23064699
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products (AGEs) activate mast cells.
Sick E; Brehin S; André P; Coupin G; Landry Y; Takeda K; Gies JP
Br J Pharmacol; 2010 Sep; 161(2):442-55. PubMed ID: 20735427
[TBL] [Abstract][Full Text] [Related]
17. Role of peroxisome proliferators-activated receptor-gamma in advanced glycation end product-mediated functional loss of voltage-gated potassium channel in rat coronary arteries.
Gao S; Hua B; Liu Q; Liu H; Li W; Li H
BMC Cardiovasc Disord; 2020 Jul; 20(1):337. PubMed ID: 32664860
[TBL] [Abstract][Full Text] [Related]
18. Thymol as a reciprocal regulator of T cell differentiation: Promotion of regulatory T cells and suppression of Th1/Th17 cells.
Namdari H; Izad M; Rezaei F; Amirghofran Z
Int Immunopharmacol; 2019 Feb; 67():417-426. PubMed ID: 30586665
[TBL] [Abstract][Full Text] [Related]
19. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells.
Kaji Y; Amano S; Usui T; Oshika T; Yamashiro K; Ishida S; Suzuki K; Tanaka S; Adamis AP; Nagai R; Horiuchi S
Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):521-8. PubMed ID: 12556378
[TBL] [Abstract][Full Text] [Related]
20. Advanced glycation endproducts influence the mRNA expression of RAGE, RANKL and various osteoblastic genes in human osteoblasts.
Franke S; Siggelkow H; Wolf G; Hein G
Arch Physiol Biochem; 2007 Jun; 113(3):154-61. PubMed ID: 17922311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
